Haleon (NYSE:HLN) & DS Healthcare Group (OTCMKTS:DSKX) Critical Analysis

DS Healthcare Group (OTCMKTS:DSKX) and Haleon (NYSE:HLN) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings and price targets for DS Healthcare Group and Haleon, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DS Healthcare Group	0	0	0	0	0.00
Haleon	0	1	4	1	3.00

Haleon has a consensus target price of $10.95, suggesting a potential upside of 14.18%. Given Haleon’s stronger consensus rating and higher possible upside, analysts clearly believe Haleon is more favorable than DS Healthcare Group.

Insider & Institutional Ownership

6.7% of Haleon shares are owned by institutional investors. 19.4% of DS Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares DS Healthcare Group and Haleon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DS Healthcare Group	N/A	N/A	N/A
Haleon	10.85%	14.76%	7.32%

Earnings & Valuation

This table compares DS Healthcare Group and Haleon”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DS Healthcare Group	N/A	N/A	N/A	N/A	N/A
Haleon	$14.05 billion	3.09	$1.30 billion	$0.34	28.21

Haleon has higher revenue and earnings than DS Healthcare Group.

Summary

Haleon beats DS Healthcare Group on 9 of the 10 factors compared between the two stocks.

About DS Healthcare Group

DS Healthcare Group, Inc. is a personal-care, product development and marketing company. The company develops and markets proprietary branded personal care products that address thinning hair conditions, skin care and other personal care needs. It research, develops and formulates its own products, consistent with its mission to provide products that make a meaningful difference in the lives of its customers. The company was founded on January 26, 2007 and is headquartered in Pompano Beach, FL.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.